Next generatio sequencing is the process of determining the precise order of nucleotides within a DNA molecule. It includes any method or technology that is used to determine the order of the four basesadenine, guanine, cytosine, and thyminein a strand of DNA. The advent of rapid DNA sequencing methods has greatly accelerated biological and medical research and discovery.
Knowledge of DNA sequences has become indispensable for basic biological research, and in numerous applied fields such as medical diagnosis, biotechnology, forensic biology, virology and biological systematics. The rapid speed of sequencing attained with modern DNA sequencing technology has been instrumental in the sequencing of complete DNA sequences, or genomes of numerous types and species of life, including the human genome and other complete DNA sequences of many animal, plant, and microbial species.

In 2018, the global Next Generation Sequencers market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

Request a sample of Managed Next Generation Sequencers Industry at: www.qyresearchreports.com/sample/sample.php?rep_id=204120...

This report focuses on the global Next Generation Sequencers status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Next Generation Sequencers development in United States, Europe and China.

The key players covered in this study
Illumina, Inc. (US)
Thermo Fisher Scientific, Inc. (US)
Pacific Biosciences of California, Inc. (US)
Roche Holding AG (Switzerland)
QIAGEN N. V. (Germany)
BGI (China)
Macrogen Inc. (South Korea)
Eurofins Scientific (Luxembourg)
Oxford Nanopore Technologies, Ltd. (UK)
Otogenetics Corporation (US)

Market segment by Type, the product can be split into
Sequencing by Synthesis (SBS)
Ion Semiconductor Sequencing
Sequencing by Ligation (SBL)
Pyrosequencing
Single-Molecule Real-time (SMRT) Sequencing
Other

Market segment by Application, split into
Diagnostics
Drug Discovery
Biomarker Discovery
Personalized Medicine
Agriculture and Animal Research
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

Read more Professional & Technical industry insights at: www.qyresearchreports.com/report/global-next-generation-s...

The study objectives of this report are:
To analyze global Next Generation Sequencers status, future forecast, growth opportunity, key market and key players.
To present the Next Generation Sequencers development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Next Generation Sequencers are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

QYResearchReports delivers the latest strategic market intelligence to build a successful business footprint in China. Our syndicated and customized research reports provide companies with vital background information of the market and in-depth analysis on the Chinese trade and investment framework, which directly affects their business operations. Reports from QYResearchReports feature valuable recommendations on how to navigate in the extremely unpredictable yet highly attractive Chinese market.

Brooklyn, NY 11230
United States
Toll Free: 866-997-4948 (USA-CANADA)
Tel: +1-518-618-1030
Web: www.qyresearchreports.com
Email: sales@qyresearchreports.com